Spain · 
Who invested in OneChain Immunotherapeutics?
OneChain Immunotherapeutics's investors include Vivo Capital and Clave Capital.
Spain · Seed startup
Who invested in OneChain Immunotherapeutics
Funding summaryUpdated 26 Oct 2026
$7.3Mraised across 1 round since 2023, from 1 source
- Latest round
- Seed, $7.3MJun 2023
- Investors
- 2
The rounds
- Jun 2023
Founders and team
From OneChain Immunotherapeutics's own website: 1 founder, 12 on the team.
- Stefanos TheoharisCEO
- Tere AcónHead of Administration
- Víctor M. Díaz CortésHead of Research
- Wilmar Castillo ÁvilaHead of Clinical Operations
- Erica Lafoz GarridoSenior Laboratory Manager
- Estibaliz Glaría PercazSenior Research Scientist
- Irene EspeltaSenior Grants and Project Manager
- Irene OliveraJunior Scientist
- Laura García PérezSenior Research Scientist
- Lidia FrancoResearch Scientist
- María José MansillaSenior Research Scientist
- Sergi CasadóResearch Scientist
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about OneChain Immunotherapeutics
How much has OneChain Immunotherapeutics raised?
OneChain Immunotherapeutics has raised $7.3M across 1 round since 2023.
When did OneChain Immunotherapeutics last raise?
OneChain Immunotherapeutics's most recent round was a Seed of $7.3M in Jun 2023.
What was OneChain Immunotherapeutics's biggest round?
Its most recent round, $7.3M in Jun 2023, is also its largest on record.
Who backed OneChain Immunotherapeutics first?
OneChain Immunotherapeutics's first round on record, in Jun 2023, was backed by Vivo Capital and Clave Capital.
What stage is OneChain Immunotherapeutics at?
OneChain Immunotherapeutics's latest named round is a Seed, in Jun 2023.
Where is OneChain Immunotherapeutics based?
OneChain Immunotherapeutics is based in Spain.
Companies like OneChain Immunotherapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.